In the rapidly evolving field of oncology, immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape for various cancers, offering...

A groundbreaking new compound named SHP1705 is generating excitement in the fight against glioblastoma, the most aggressive and lethal brain...

In the complex landscape of oncology, the ErbB family of receptor tyrosine kinases has long captivated researchers with its pivotal...

The nuclear pore complex protein RANBP2 has recently gained significant attention within the realm of cancer biology due to its...

Recent groundbreaking research out of Amsterdam University Medical Center (Amsterdam UMC) has shed new light on the safety profile of...

The intricate relationship between RNA-binding proteins (RBPs) and circular RNAs (circRNAs) has rapidly ascended as a focal point in molecular...

In the evolving battleground of oncology, few molecular targets have captured as much attention and complexity as the MYC protein....

Biliary tract cancers (BTC) represent a formidable challenge in oncology, encompassing a diverse and aggressive group of malignancies originating in...

In a groundbreaking analysis published in the upcoming issue of Annals of Internal Medicine, researchers from the German Cancer Research...

In a groundbreaking advance poised to reshape the landscape of radiation therapy, researchers at The University of Texas at Arlington...